(IT) Gartner - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3666511072
Stock: Research, Conferences, Consulting
Total Rating 41
Risk 98
Buy Signal -0.01
| Risk 5d forecast | |
|---|---|
| Volatility | 43.0% |
| Relative Tail Risk | -8.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.98 |
| Alpha | -85.67 |
| Character TTM | |
|---|---|
| Beta | 0.867 |
| Beta Downside | 0.132 |
| Drawdowns 3y | |
|---|---|
| Max DD | 73.73% |
| CAGR/Max DD | -0.27 |
EPS (Earnings per Share)
Revenue
Description: IT Gartner March 04, 2026
Gartner Inc. (IT) provides business and technology advisory services globally. Its business model focuses on subscription-based research, conferences, and consulting.
The company operates in the IT Consulting & Other Services sector, which is characterized by high demand for digital transformation and strategic technology guidance.
Gartners Insights segment offers access to proprietary research and expert networks. The Conferences segment facilitates networking and knowledge sharing among executives. The Consulting segment provides tailored strategic advice and support for IT initiatives like cost optimization and digital transformation.
For further detailed analysis on Gartners performance and market position, consider exploring ValueRay.
Headlines to watch out for
- Subscription retention rates impact recurring revenue growth
- Conference attendance drives event segment performance
- Consulting project demand reflects enterprise IT spending
- Economic downturns reduce client research and advisory budgets
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 729.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -1.67 > 1.0 |
| NWC/Revenue: -0.09% < 20% (prev 3.63%; Δ -3.72% < -1%) |
| CFO/TA 0.16 > 3% & CFO 1.29b > Net Income 729.2m |
| Net Debt (1.63b) to EBITDA (1.23b): 1.32 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (72.1m) vs 12m ago -7.56% < -2% |
| Gross Margin: 67.66% > 18% (prev 0.68%; Δ 6.70k% > 0.5%) |
| Asset Turnover: 78.19% > 50% (prev 73.43%; Δ 4.75% > 0%) |
| Interest Coverage Ratio: 16.98 > 6 (EBITDA TTM 1.23b / Interest Expense TTM 60.6m) |
Altman Z'' 4.44
| A: -0.00 (Total Current Assets 4.07b - Total Current Liabilities 4.07b) / Total Assets 8.09b |
| B: 0.83 (Retained Earnings 6.72b / Total Assets 8.09b) |
| C: 0.12 (EBIT TTM 1.03b / Avg Total Assets 8.31b) |
| D: 0.86 (Book Value of Equity 6.68b / Total Liabilities 7.77b) |
| Altman-Z'' Score: 4.44 = AA |
Beneish M -3.09
| DSRI: 0.98 (Receivables 1.73b/1.70b, Revenue 6.50b/6.27b) |
| GMI: 1.00 (GM 67.66% / 67.72%) |
| AQI: 0.99 (AQ_t 0.44 / AQ_t-1 0.45) |
| SGI: 1.04 (Revenue 6.50b / 6.27b) |
| TATA: -0.07 (NI 729.2m - CFO 1.29b) / TA 8.09b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of IT shares?
As of March 15, 2026, the stock is trading at USD 160.39 with a total of 1,347,576 shares traded.
Over the past week, the price has changed by -1.34%, over one month by +5.15%, over three months by -32.32% and over the past year by -63.12%.
Over the past week, the price has changed by -1.34%, over one month by +5.15%, over three months by -32.32% and over the past year by -63.12%.
Is IT a buy, sell or hold?
Gartner has received a consensus analysts rating of 3.55.
Therefor, it is recommend to hold IT.
- StrongBuy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the IT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 190.5 | 18.7% |
| Analysts Target Price | 190.5 | 18.7% |
IT Fundamental Data Overview March 10, 2026
P/E Trailing = 17.2425
P/E Forward = 12.7877
P/S = 1.8459
P/B = 37.2173
P/EG = 0.8664
Revenue TTM = 6.50b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.23b USD
Long Term Debt = 2.98b USD (from longTermDebt, last quarter)
Short Term Debt = 101.1m USD (from shortTermDebt, last quarter)
Debt = 3.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.63b USD (from netDebt column, last quarter)
Enterprise Value = 13.62b USD (11.99b + Debt 3.35b - CCE 1.72b)
Interest Coverage Ratio = 16.98 (Ebit TTM 1.03b / Interest Expense TTM 60.6m)
EV/FCF = 11.59x (Enterprise Value 13.62b / FCF TTM 1.18b)
FCF Yield = 8.63% (FCF TTM 1.18b / Enterprise Value 13.62b)
FCF Margin = 18.09% (FCF TTM 1.18b / Revenue TTM 6.50b)
Net Margin = 11.22% (Net Income TTM 729.2m / Revenue TTM 6.50b)
Gross Margin = 67.66% ((Revenue TTM 6.50b - Cost of Revenue TTM 2.10b) / Revenue TTM)
Gross Margin QoQ = 64.60% (prev 68.88%)
Tobins Q-Ratio = 1.68 (Enterprise Value 13.62b / Total Assets 8.09b)
Interest Expense / Debt = 0.57% (Interest Expense 19.1m / Debt 3.35b)
Taxrate = 22.85% (71.7m / 313.8m)
NOPAT = 793.6m (EBIT 1.03b * (1 - 22.85%))
Current Ratio = 1.00 (Total Current Assets 4.07b / Total Current Liabilities 4.07b)
Debt / Equity = 10.47 (Debt 3.35b / totalStockholderEquity, last quarter 319.9m)
Debt / EBITDA = 1.32 (Net Debt 1.63b / EBITDA 1.23b)
Debt / FCF = 1.38 (Net Debt 1.63b / FCF TTM 1.18b)
Total Stockholder Equity = 976.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.77% (Net Income 729.2m / Total Assets 8.09b)
RoE = 74.65% (Net Income TTM 729.2m / Total Stockholder Equity 976.7m)
RoCE = 26.02% (EBIT 1.03b / Capital Employed (Equity 976.7m + L.T.Debt 2.98b))
RoIC = 22.24% (NOPAT 793.6m / Invested Capital 3.57b)
WACC = 7.22% (E(11.99b)/V(15.34b) * Re(9.11%) + D(3.35b)/V(15.34b) * Rd(0.57%) * (1-Tc(0.23)))
Discount Rate = 9.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.47%
[DCF] Terminal Value 81.45% ; FCFF base≈1.26b ; Y1≈1.30b ; Y5≈1.46b
[DCF] Fair Price = 405.1 (EV 30.17b - Net Debt 1.63b = Equity 28.54b / Shares 70.5m; r=7.22% [WACC]; 5y FCF grow 3.16% → 2.90% )
EPS Correlation: -15.45 | EPS CAGR: 10.25% | SUE: 0.16 | # QB: 0
Revenue Correlation: 82.19 | Revenue CAGR: 9.14% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.69 | Chg7d=-0.006 | Chg30d=-0.029 | Revisions Net=+0 | Analysts=14
EPS current Year (2026-12-31): EPS=13.17 | Chg7d=-0.004 | Chg30d=-0.293 | Revisions Net=-4 | Growth EPS=-0.0% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=14.51 | Chg7d=+0.025 | Chg30d=-0.370 | Revisions Net=-3 | Growth EPS=+10.2% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.00 (6 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 9.1% - Earnings Yield 5.8%)
[Growth] Growth Spread = -3.5% (Analyst -0.1% - Implied 3.3%)
P/E Forward = 12.7877
P/S = 1.8459
P/B = 37.2173
P/EG = 0.8664
Revenue TTM = 6.50b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.23b USD
Long Term Debt = 2.98b USD (from longTermDebt, last quarter)
Short Term Debt = 101.1m USD (from shortTermDebt, last quarter)
Debt = 3.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.63b USD (from netDebt column, last quarter)
Enterprise Value = 13.62b USD (11.99b + Debt 3.35b - CCE 1.72b)
Interest Coverage Ratio = 16.98 (Ebit TTM 1.03b / Interest Expense TTM 60.6m)
EV/FCF = 11.59x (Enterprise Value 13.62b / FCF TTM 1.18b)
FCF Yield = 8.63% (FCF TTM 1.18b / Enterprise Value 13.62b)
FCF Margin = 18.09% (FCF TTM 1.18b / Revenue TTM 6.50b)
Net Margin = 11.22% (Net Income TTM 729.2m / Revenue TTM 6.50b)
Gross Margin = 67.66% ((Revenue TTM 6.50b - Cost of Revenue TTM 2.10b) / Revenue TTM)
Gross Margin QoQ = 64.60% (prev 68.88%)
Tobins Q-Ratio = 1.68 (Enterprise Value 13.62b / Total Assets 8.09b)
Interest Expense / Debt = 0.57% (Interest Expense 19.1m / Debt 3.35b)
Taxrate = 22.85% (71.7m / 313.8m)
NOPAT = 793.6m (EBIT 1.03b * (1 - 22.85%))
Current Ratio = 1.00 (Total Current Assets 4.07b / Total Current Liabilities 4.07b)
Debt / Equity = 10.47 (Debt 3.35b / totalStockholderEquity, last quarter 319.9m)
Debt / EBITDA = 1.32 (Net Debt 1.63b / EBITDA 1.23b)
Debt / FCF = 1.38 (Net Debt 1.63b / FCF TTM 1.18b)
Total Stockholder Equity = 976.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.77% (Net Income 729.2m / Total Assets 8.09b)
RoE = 74.65% (Net Income TTM 729.2m / Total Stockholder Equity 976.7m)
RoCE = 26.02% (EBIT 1.03b / Capital Employed (Equity 976.7m + L.T.Debt 2.98b))
RoIC = 22.24% (NOPAT 793.6m / Invested Capital 3.57b)
WACC = 7.22% (E(11.99b)/V(15.34b) * Re(9.11%) + D(3.35b)/V(15.34b) * Rd(0.57%) * (1-Tc(0.23)))
Discount Rate = 9.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.47%
[DCF] Terminal Value 81.45% ; FCFF base≈1.26b ; Y1≈1.30b ; Y5≈1.46b
[DCF] Fair Price = 405.1 (EV 30.17b - Net Debt 1.63b = Equity 28.54b / Shares 70.5m; r=7.22% [WACC]; 5y FCF grow 3.16% → 2.90% )
EPS Correlation: -15.45 | EPS CAGR: 10.25% | SUE: 0.16 | # QB: 0
Revenue Correlation: 82.19 | Revenue CAGR: 9.14% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.69 | Chg7d=-0.006 | Chg30d=-0.029 | Revisions Net=+0 | Analysts=14
EPS current Year (2026-12-31): EPS=13.17 | Chg7d=-0.004 | Chg30d=-0.293 | Revisions Net=-4 | Growth EPS=-0.0% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=14.51 | Chg7d=+0.025 | Chg30d=-0.370 | Revisions Net=-3 | Growth EPS=+10.2% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.00 (6 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 9.1% - Earnings Yield 5.8%)
[Growth] Growth Spread = -3.5% (Analyst -0.1% - Implied 3.3%)